News

Home News

05

Dec2022

PMPRB’s 2021 Annual Report Shows Worrying Decline in Number of New Medicines Launched in Canada; HDAP Meeting Tentatively Scheduled for Spring 2023

/ News, PMPRB
Last week the Patented Medicine Prices Review Board (PMPRB) presented its 2021 Annual Report  to Federal ... Read More

05

Dec2022

PDCI Well Wishes for Managing Director Kaitlyn Proulx

/ News, PDCI
PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November ... Read More

05

Dec2022

CADTH Pharmaceutical Reviews Update Includes Launch of RWE Guidance Consultation

/ CADTH, News
On November 10, 2022, among other procedural updates included in the CADTH Pharmaceutical Reviews Update Issue 32, CADTH published ... Read More

22

Nov2022

PDCI Launches Sharing Page for PMRPB Consultation on Draft Guidelines- Fall 2022

/ Canada, PMPRB
On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) published its Draft price regulatory Guidelines and ... Read More

22

Nov2022

CADTH Pharmaceutical Reviews Update Includes Launch of RWE Guidance Consultation

/ CADTH, Canada, What's New
On November 10, 2022, among other procedural updates included in the CADTH Pharmaceutical Reviews Update Issue 32, CADTH published ... Read More

13

Oct2022

PDCI’s Early Insights on PMPRB Draft Guidelines

/ News, PMPRB
On October 6, 2022, the Patented Medicine Prices Review Board (PMPRB) published its highly anticipated draft price regulatory ... Read More

06

Oct2022

PMPRB Releases Draft Guidelines and Launches 60-day consultation 

/ News, PMPRB, What's New
The Patented Medicine Prices Review Board (PMPRB) today, Ocober 6, 2022, released its draft PMPRB ... Read More

19

Aug2022

PMPRB Implements its Interim Guidelines with Clarifications

/ PMPRB, What's New
On August 18, 2022, PMPRB announced its decisions regarding Price Regulation of patented medicines during the ‘Interim Period’, ... Read More